NRX Pharmaceuticals (NRXP) Goodwill & Intangibles (2025 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Goodwill & Intangibles came in at $2.7 million in Q1 2026, down 1.69% on a QoQ basis from $2.7 million in Q4 2025.
NRX Pharmaceuticals (NRXP) Goodwill & Intangibles (2025 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 2 years of Goodwill & Intangibles data on file, last reported at $2.7 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.7 million, changed N/A from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $2.7 million, down from $2.7 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for NRXP reached as high as $2.7 million in Q4 2025 and fell as low as $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | NRX Pharmaceuticals | 116.05 Mn | 109.35 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.67 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 2.39 Mn |